Glimsea MV 1mg/500mg/0.2mg Tablet SR
Marketer
Seashell Laboratories Private Limited
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Glimsea MV 1mg/500mg/0.2mg Tablet SR
Glimsea MV 1mg/500mg/0.2mg extended-release tablets are classified as antidiabetic medications. This combination therapy is indicated for managing type 2 diabetes in adults, effectively regulating blood glucose. Administer Glimsea MV with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continue taking this medication as prescribed, even if feeling well, as discontinuation without medical consultation can lead to elevated blood sugar, potentially causing kidney complications, vision loss, neuropathy, and limb amputation. Remember, this medication is part of a comprehensive treatment plan incorporating diet, exercise, and weight management as recommended by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is the most prevalent adverse effect. Learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to counteract them. Regular meals and carrying a fast-acting glucose source (e.g., sugary snacks or juice) are crucial. Alcohol consumption increases hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Inform your doctor of any history of heart disease before commencing treatment; it may be unsuitable. Pregnant or breastfeeding individuals should consult their doctor prior to use. Regular blood glucose monitoring is essential, and your physician may recommend blood tests to assess blood cell counts and liver function.
Uses of Glimsea MV 1mg/500mg/0.2mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glimsea MV 1mg/500mg/0.2mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet without chewing, crushing, or fracturing it. Administer Glimsea MV 1mg/500mg/0.2mg Extended-Release Tablet on an empty stomach.
Common Side effects of Glimsea MV 1mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glimsea MV 1mg/500mg/0.2mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Glimsea MV 1mg/500mg/0.2mg Extended-Release Tablet on an empty stomach.
How Glimsea MV 1mg/500mg/0.2mg Tablet SR works:
Glimsea MV SR tablets (1mg/500mg/0.2mg) contain a triple-action formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimsea MV 1mg/500mg/0.2mg SR tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Glimsea MV 1mg/500mg/0.2mg Extended-Release Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Seek medical advice before taking this drug.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glimsea MV 1mg/500mg/0.2mg tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired if your blood glucose level is abnormally low or high. Refrain from driving if such symptoms arise.
KidneyUNSAFE
Employing Glimsea MV 1mg/500mg/0.2mg Tablet SR carries a high likelihood of risk for individuals with kidney impairment and is best omitted. Medical advice is recommended. Furthermore, its use is contraindicated in patients experiencing severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Glimsea MV 1mg/500mg/0.2mg SR tablets cautiously, potentially requiring dose modification. Consult a physician. For those with mild to moderate liver disease, Glimsea MV 1mg/500mg/0.2mg SR tablets are typically initiated at a low dose; however, it's contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Glimsea MV 1mg/500mg/0.2mg Tablet SR :
Should you forget to take a Glimsea MV 1mg/500mg/0.2mg Tablet SR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Glimsea MV 1mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently